endoscout | Mediathek

Produkt
Katalog

Alle Produkte auf einen Blick zum durchblättern

jetzt entdecken

Publikationen

2020

Drug-coated Balloon Angioplasty of Femoropopliteal Lesions Maintained Superior Efficacy over Conventional Balloon: 2-year Results of the Randomized EffPac Trial

luminor

öffnen

Efficacy and Safety of a Novel Paclitaxel-Nano-Coated Balloon for Femoro-Popliteal Angioplasty: 1-Year Results of EffPac Trial

luminor

öffnen

2019

Incidental findings during computed tomographicangiography diagnostic work-up in patients witharteriogenic erectile dysfunction

öffnen

Erektile Dysfunktion – ein Marker für generalisierte Arteriosklerose

öffnen

Multivariable Regression Analysis of Clinical Data from the Randomized- Controlled EffPac Trial: Efficacy of Femoropopliteal Drug-Coated Balloon Angioplasty

luminor

öffnen

Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis

öffnen

Not all DCBs are the same - New-generation coating technologies can influence safety and effectiveness.

luminor

öffnen

Mortality Not Correlated With Paclitaxel Exposure - An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon

öffnen

Endovascular Therapy for Erectile Dysfunction—Who Benefits Most_ Insights From a Single-Center Experience

angiolite BTK

öffnen

2018

Recanalization of bilateral axillaris/brachialis artery occlusion in a patient with Takayashu arteritis: First case report on using a novel drug‐coated nitinol “chocolate” balloon catheter

chocolate touch

öffnen

2017

Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study

angiolite

öffnen

Erectile dysfunction – overview from a cardiovascular perspective

öffnen

Erektile Dysfunktion vaskulärer Genese

öffnen

Veranstaltungen

LINC2020 - Leipzig Interventional Course

Drug-coated balloon angioplasty of femoropopliteal lesions maintained superiority over standard balloon – 2-year results of the randomized EffPac trial

luminor

öffnen

T.I.N.T.I.N. trial : Final 12-month data with the combination of Luminor DCB + iVolution stent in TASC C and D lesions

luminor, iVolution

öffnen

NiTiDES: From theory to practice

NiTiDES

öffnen

Why, when and where: the DES role in SFA treatment

NiTiDES

öffnen

The ILLUMINA Study: 2-year results with a polymer free Sirolimus eluting DES in femoropopliteal arteries

NiTiDES

öffnen

NiTiDES : the innovative approach of SFA lesions

NiTiDES

öffnen

EuroPCR 2019

EFFPAC trial: Effectiveness of Luminor DCB vs. POBA in the SFA: 24-month safety and efficacy outcomes (U. Teichgräber)

luminor

öffnen

ANGIOLITE trial two-year follow-up. Non-inferiority randomized clinical trial comparing the efficacy and safety of Angiolite vs Xience (A. Perez de Prado)

angiolite

öffnen

Angiographic and optical coherence tomography assessment in follow up of a new paclitaxel-eluting balloon, with an ultrasonic nanotechnology drop dosage system, for the treatment of in-stent restenosis (J. de la Torre)

essential

öffnen

LINC 2019 - Leipzig Interventional Course

Best DCB outcomes in SFA TASC A&B lesions: EFFPAC-RCT 12-months follow-up (U. Teichgräber)

luminor

öffnen

24-month outcomes in the EVOLUTION study - Investigating the iVolution stent in fempop lesions (M. Bosiers)

iVolution

öffnen

DCB in SFA complex lesions : 1 + 1 = 3 TINTIN trial first outcomes (K. Deloose)

luminor, iVolution

öffnen

State of the Art of BTK Vessel treatment (S. Sixt)

luminor

öffnen

BIBLIOS STUDY (K. Deloose)

luminor

öffnen

CIRSE 2018

Innovating SFA lesions treatment with NiTiDES (R. Langhoff)

NiTiDES

öffnen

The ILLUMINA Study NiTiDES First In Human Trial (D. Scheinert)

NiTiDES

öffnen

CX Symposium 2018

EffPac-Trial: Effectiveness of LUMINOR® DCB versus POBA in the SFA: 12 months results (U. Teichgräber)

luminor

öffnen

Below-the-knee dedicated sirolimus eluting stent : 6 months results (P. Goverde)

angiolite BTK

öffnen

LINC 2018 - Leipzig Interventional Course

EFFPAC–RCT: Final 6-months results with the Luminor DCB in femoropopliteal lesions (D. Scheinert)

luminor

öffnen

Is Luminor DCB the best choice for femoropopliteal lesions? EffPac-RCT, 6-month data (U. Teichgräber)

luminor

öffnen

Luminor DCB makes it different and favourable in CLI (LUMINOR registry, 12-month data) (V. Riambau)

luminor

öffnen

Evolution Or is the iVolution stent a better alternative? EVOLUTION 12-month data (M. Bosiers)

iVolution

öffnen

6-month results of real-life use of the latest generation of balloon expandable DES in below-the-knee treatment (P. Goverde)

angiolite BTK

öffnen

Is there still any space left for DES in the BTK area ??? (Angiolite BTK trial, 6 month Data) (P. Goverde)

angiolite BTK

öffnen

Spot Stenting with VascuFlex Multi-Loc (P. Goverde)

VascuFlex® Multi-LOC

öffnen

LOCOMOTIVE All Comers Registry with the Multi-Loc spot stenting device: 12-month results (K. Amendt)

VascuFlex® Multi-LOC

öffnen

MAKE COMBINATION THERAPY GREAT AGAIN DCBS AND AND SPOT STENTS IN FEMPOP LESIONS (G. Tepe)

VascuFlex® Multi-LOC

öffnen

LINC 2017 - Leipzig Interventional Course

Final Results of the Feasibility Study for the Drug-coated Chocolate Touch PTA balloon of Femoropopliteal lesions: The ENDURE Trial (A. Holden)

Chocolate touch

öffnen

New manufacturing process and stent design are key elements to improve clinical outcome (P. Goverde)

iVolution

öffnen

First 6-month results in 75 patients in the EVOLUTION study (M. Bosiers)

iVolution

öffnen

LUMINOR registry: a real world experience with a new DEB in advanced limb ischemia (V. Riambau)

luminor

öffnen

EffPac – Trial: Assessment of the Effectiveness of DCB versus POBA in the SFA (U. Teichgräber)

luminor

öffnen

6-month results of the LOCOMOTIVE registry investigating spot stenting in the femoropopliteal tract (K. Amendt)

VascuFlex® Multi-LOC

öffnen

ProduktKatalog

Publikationen

2020

Drug-coated Balloon Angioplasty of Femoropopliteal Lesions Maintained Superior Efficacy over Conventional Balloon: 2-year Results of the Randomized EffPac Trial

Efficacy and Safety of a Novel Paclitaxel-Nano-Coated Balloon for Femoro-Popliteal Angioplasty: 1-Year Results of EffPac Trial

2019

Incidental findings during computed tomographicangiography diagnostic work-up in patients witharteriogenic erectile dysfunction

Erektile Dysfunktion – ein Marker für generalisierte Arteriosklerose

Multivariable Regression Analysis of Clinical Data from the Randomized- Controlled EffPac Trial: Efficacy of Femoropopliteal Drug-Coated Balloon Angioplasty

Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis

Not all DCBs are the same - New-generation coating technologies can influence safety and effectiveness.

Mortality Not Correlated With Paclitaxel Exposure - An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon

Endovascular Therapy for Erectile Dysfunction—Who Benefits Most_ Insights From a Single-Center Experience

2018

Recanalization of bilateral axillaris/brachialis artery occlusion in a patient with Takayashu arteritis: First case report on using a novel drug‐coated nitinol “chocolate” balloon catheter

2017

Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study

Erectile dysfunction – overview from a cardiovascular perspective

Erektile Dysfunktion vaskulärer Genese

Veranstaltungen

LINC2020 - Leipzig Interventional Course

Drug-coated balloon angioplasty of femoropopliteal lesions maintained superiority over standard balloon – 2-year results of the randomized EffPac trial

T.I.N.T.I.N. trial : Final 12-month data with the combination of Luminor DCB + iVolution stent in TASC C and D lesions

NiTiDES: From theory to practice

Why, when and where: the DES role in SFA treatment

The ILLUMINA Study: 2-year results with a polymer free Sirolimus eluting DES in femoropopliteal arteries

NiTiDES : the innovative approach of SFA lesions

EuroPCR 2019

EFFPAC trial: Effectiveness of Luminor DCB vs. POBA in the SFA: 24-month safety and efficacy outcomes (U. Teichgräber)

ANGIOLITE trial two-year follow-up. Non-inferiority randomized clinical trial comparing the efficacy and safety of Angiolite vs Xience (A. Perez de Prado)

Angiographic and optical coherence tomography assessment in follow up of a new paclitaxel-eluting balloon, with an ultrasonic nanotechnology drop dosage system, for the treatment of in-stent restenosis (J. de la Torre)

LINC 2019 - Leipzig Interventional Course

Best DCB outcomes in SFA TASC A&B lesions: EFFPAC-RCT 12-months follow-up (U. Teichgräber)

24-month outcomes in the EVOLUTION study - Investigating the iVolution stent in fempop lesions (M. Bosiers)

DCB in SFA complex lesions : 1 + 1 = 3 TINTIN trial first outcomes (K. Deloose)

State of the Art of BTK Vessel treatment (S. Sixt)

BIBLIOS STUDY (K. Deloose)

CIRSE 2018

Innovating SFA lesions treatment with NiTiDES (R. Langhoff)

The ILLUMINA Study NiTiDES First In Human Trial (D. Scheinert)

CX Symposium 2018

EffPac-Trial: Effectiveness of LUMINOR® DCB versus POBA in the SFA: 12 months results (U. Teichgräber)

Below-the-knee dedicated sirolimus eluting stent : 6 months results (P. Goverde)

LINC 2018 - Leipzig Interventional Course

EFFPAC–RCT: Final 6-months results with the Luminor DCB in femoropopliteal lesions (D. Scheinert)

Is Luminor DCB the best choice for femoropopliteal lesions? EffPac-RCT, 6-month data (U. Teichgräber)

Luminor DCB makes it different and favourable in CLI (LUMINOR registry, 12-month data) (V. Riambau)

Evolution Or is the iVolution stent a better alternative? EVOLUTION 12-month data (M. Bosiers)

6-month results of real-life use of the latest generation of balloon expandable DES in below-the-knee treatment (P. Goverde)

Is there still any space left for DES in the BTK area ??? (Angiolite BTK trial, 6 month Data) (P. Goverde)

Spot Stenting with VascuFlex Multi-Loc (P. Goverde)

LOCOMOTIVE All Comers Registry with the Multi-Loc spot stenting device: 12-month results (K. Amendt)

MAKE COMBINATION THERAPY GREAT AGAIN DCBS AND AND SPOT STENTS IN FEMPOP LESIONS (G. Tepe)

LINC 2017 - Leipzig Interventional Course

Final Results of the Feasibility Study for the Drug-coated Chocolate Touch PTA balloon of Femoropopliteal lesions: The ENDURE Trial (A. Holden)

New manufacturing process and stent design are key elements to improve clinical outcome (P. Goverde)

First 6-month results in 75 patients in the EVOLUTION study (M. Bosiers)

LUMINOR registry: a real world experience with a new DEB in advanced limb ischemia (V. Riambau)

EffPac – Trial: Assessment of the Effectiveness of DCB versus POBA in the SFA (U. Teichgräber)

6-month results of the LOCOMOTIVE registry investigating spot stenting in the femoropopliteal tract (K. Amendt)

Produkt
Katalog